Fingerprint
Dive into the research topics of 'Randomized, noncomparative, phase II trial of early switch from docetaxel to cabazitaxel or vice versa, with integrated biomarker analysis, in men with chemotherapy-naïve, metastatic, castration-resistant prostate cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically